Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Published reports suggest that immune checkpoint inhibitors (ICIs) before allogeneic blood or marrow transplantation (alloBMT) may increase the incidence of graft-versus-host disease (GvHD), immune-related adverse events, and nonrelapse mortality (NRM); this led to the US Food and Drug Administratio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Schoch, Laura K., Cooke, Kenneth R., Wagner-Johnston, Nina D., Gojo, Ivana, Swinnen, Lode J., Imus, Philip, Fuchs, Ephraim J., Levis, Mark, Ambinder, Richard F., Jones, Richard J., Gladstone, Douglas E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134225/
https://ncbi.nlm.nih.gov/pubmed/30190282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018019208
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados